Literature DB >> 22469737

Cirrhosis should not be considered as an absolute contraindication for pancreatoduodenectomy.

David Fuks1, Charles Sabbagh, Thierry Yzet, Richard Delcenserie, Denis Chatelain, Jean-Marc Regimbeau.   

Abstract

BACKGROUND/AIMS: Liver cirrhosis is considered to be a contraindication for pancreaticoduodenectomy (PD). The aim of this study was to present 4 cases of successful PD in cirrhotic patients.
METHODOLOGY: Among the charts of 90 patients who underwent PD between 2004 and 2008, 4 patients with liver cirrhosis were retrospectively reviewed.
RESULTS: There were 3 males and 1 female, aged from 53 to 66 years, who underwent PD for pancreatic head adenocarcinoma (n=3) or ampullary carcinoma (n=1). The median tumor size was 21mm (18-26) and 2 patients had preoperative biliary drainage. All patients had biopsy showing cancer prior to the operation. Cirrhosis was preoperatively suspected due to chronic alcoholism or liver dismorphy on CTscan and confirmed histologically in all patients. All patients were Child Pugh A without portal hypertension. The median operating time was 575 minutes (480-600) and 2 patients received an intraoperative blood transfusion. No patient died postoperatively. All patients had postoperative complications: ascites (n=2), pancreatic fistula (soft pancreas) (n=2) and pulmonary infection (n=1). There was neither liver failure nor postoperative bleeding. Two patients required re-operation for suspected mesenteric ischemia (n=1) and pancreatic fistula (n=1). The median length of hospitalization was 50 days (41-74). The median survival was 12.5 months (3 patients are alive and disease free).
CONCLUSIONS: Our data shows that PD in patients with Child A liver cirrhosis should not be systematically considered as a contraindication.

Entities:  

Mesh:

Year:  2012        PMID: 22469737     DOI: 10.5754/hge10509

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  4 in total

1.  Efficacy of the double-pigtail stent as a conservative treatment for grade B pancreatic fistula after pancreatoduodenectomy with pancreatogastric anastomosis.

Authors:  Eric Bartoli; Lionel Rebibo; Brice Robert; Mathurin Fumery; Richard Delcenserie; Jean-Marc Regimbeau
Journal:  Surg Endosc       Date:  2013-12-14       Impact factor: 4.584

2.  The Impact of Cirrhosis on Pancreatic Cancer Surgery: A Systematic Review and Meta-Analysis.

Authors:  Dimitrios Schizas; Spyridon Peppas; Stefanos Giannopoulos; Vasiliki Lagopoulou; Konstantinos S Mylonas; Spyridon Giannopoulos; Dimitrios Moris; Evangelos Felekouras; Konstantinos Toutouzas
Journal:  World J Surg       Date:  2020-10-18       Impact factor: 3.352

3.  Impact of cirrhosis on surgical outcome after pancreaticoduodenectomy.

Authors:  Ayman El Nakeeb; Ahmad M Sultan; Tarek Salah; Mohamed El Hemaly; Emad Hamdy; Ali Salem; Ahmed Moneer; Rami Said; Ahmed AbuEleneen; Mostafa Abu Zeid; Talaat Abdallah; Mohamed Abdel Wahab
Journal:  World J Gastroenterol       Date:  2013-11-07       Impact factor: 5.742

4.  Distal pancreatectomy with splenorenal shunt to preserve spleen in a cirrhotic patient.

Authors:  Giuseppe Maria Ettorre; Giovanni Battista Levi Sandri; Marco Colasanti; Edoardo de Werra; Pasquale Lepiane
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2017-05-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.